SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
(Mark One)
þ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) |
||||||||
|
OF THE SECURITIES EXCHANGE ACT OF 1934 |
||||||||
|
|
||||||||
|
For the quarterly period ended June 30, 2003 |
||||||||
|
|
||||||||
|
OR |
||||||||
|
|
||||||||
o |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE |
||||||||
|
SECURITIES EXCHANGE ACT OF 1934 |
||||||||
|
|
||||||||
|
|
For the Transition period from |
|
to |
|
|
|
||
|
|
||||||||
|
Commission file number 1-12372 |
||||||||
|
|
||||||||
|
CYTEC INDUSTRIES INC. |
||||||||
|
(Exact name of registrant as specified in its charter) |
||||||||
|
|
||||||||
|
Delaware |
|
22-3268660 |
|
|||||
|
(State or other jurisdiction of |
|
(I.R.S. Employer |
|
|||||
|
incorporation or organization) |
|
|
|
|||||
|
|
||||||||
|
Five Garret Mountain Plaza |
||||||||
|
West Paterson, New Jersey 07424 |
||||||||
|
(Address of principal executive offices) |
||||||||
|
|
||||||||
|
973-357-3100 |
||||||||
|
(Registrant's telephone number, including area code) |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes þ No
o
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes þ No o
Therewere 39,043,558 shares of common stock outstanding at July 25, 2003.
1
INDEX
|
|
|
|
|
|
|
|
|
|
|
|
Page |
|||
|
|
|
|
-------- |
|||
Part I - Financial Information |
|
|
|
|
|||
|
Item 1. |
|
Consolidated Financial Statements |
|
|
3 |
|
|
|
|
Consolidated Statements of Income |
|
|
3 |
|
|
|
|
Consolidated Balance Sheets |
|
|
4 |
|
|
|
|
Consolidated Statements of Cash Flows |
|
|
5 |
|
|
|
|
Notes to Consolidated Financial Statements |
|
|
6 |
|
|
Item 2. |
|
Management's Discussion and Analysis of Financial Condition and Results of Operations |
|
|
16 |
|
|
Item 3. |
|
Quantitative And Qualitative Disclosures About Market Risk |
|
|
24 |
|
|
Item 4. |
|
Controls and Procedures |
|
|
25 |
|
|
|||||||
Part II - Other Information |
|
|
|
|
|||
|
Item 1. |
|
Legal Proceedings |
|
|
26 |
|
|
Item 4 |
|
Submission of Matters to a Vote of Security Holders |
|
|
27 |
|
|
Item 6. |
|
Exhibits and Reports on Form 8-K |
|
|
28 |
|
|
|
|
|
|
|
|
|
Signatures |
|
|
|
|
29 |
|
|
Exhibit Index |
|
|
|
|
30 |
|
|
|
2
PART I - FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
CYTEC INDUSTRIES INC.
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(Millions of dollars, except per share amounts)
|
Three Months |
|
Six Months |
||
|
----------------------------------- |
|
---------------------------------- |
||
|
2003 |
2002 |
|
2003 |
2002 |
|
-------------- |
-------------- |
|
------------- |
--------------- |
Net sales |
$ 374.9 |
$ 350.9 |
|
$ 742.2 |
$ 668.9 |
|
|
|
|
|
|
Manufacturing cost of sales |
279.0 |
263.9 |
|
551.4 |
511.8 |
Selling and technical services |
31.2 |
30.0 |
|
61.2 |
61.8 |
Research and process development |
8.8 |
8.3 |
|
17.0 |
17.2 |
Administrative and general |
13.8 |
13.3 |
|
25.6 |
26.5 |
Amortization of acquisition intangibles |
0.8 |
0.8 |
|
1.6 |
1.6 |
|
------------ |
------------ |
|
------------ |
------------ |
Earnings from operations |
41.3 |
34.6 |
|
85.4 |
50.0 |
|
|
|
|
|
|
Other income (expense), net |
(2.5) |
0.3 |
|
(3.7) |
(0.6) |
Equity in earnings of associated companies |
0.5 |
2.1 |
|
3.1 |
3.3 |
Interest expense, net |
3.0 |
4.9 |
|
7.2 |
10.0 |
|
------------ |
------------ |
|
------------ |
------------ |
Earnings before income taxes and cumulative |
36.3 |
32.1 |
|
77.6 |
42.7 |
|
|
|
|
|
|
Income tax provision |
10.9 |
10.7 |
|
23.3 |
14.3 |
|
------------ |
------------ |
|
------------ |
------------ |
Earnings before cumulative effect of a change in |
|
|
|
|
|
|
------------ |
------------ |
|
------------ |
------------ |
Cumulative effect of a change in accounting |
|
|
|
|
|
|
|
|
|
|
|
Net earnings |
$ 25.4 |
$ 21.4 |
|
$ 40.7 |
$ 28.4 |
|
======= |
======= |
|
======= |
======= |
|
|
|
|
|
|
Earnings before cumulative effect of a change |
|
|
|
|
|
Basic |
$0.65 |
$0.54 |
|
$1.40 |
$0.72 |
Diluted |
$0.64 |
$0.52 |
|
$1.36 |
$0.70 |
|
|
|
|
|
|
Cumulative effect of a change in accounting |
|
|
|
|
|
Basic |
- |
- |
|
$(0.35) |
- |
Diluted |
- |
- |
|
$(0.34) |
- |
|
|
|
|
|
|
Earnings per common share |
|
|
|
|
|
Basic |
$0.65 |
$0.54 |
|
$1.05 |
$0.72 |
Diluted |
$0.64 |
$0.52 |
|
$1.02 |
$0.70 |
|
|
|
|
|
|
See accompanying Notes to Consolidated Financial Statements.
3
CYTEC INDUSTRIES INC.
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Millions of dollars, except share and per share amounts)
|
June 30, |
|
December 31, |
ASSETS |
|
|
|
Current assets |
|
|
|
Cash and cash equivalents |
$ 309.2 |
|
$ 210.0 |
Accounts receivable, less allowance for doubtful accounts |
|
|
|
Other accounts receivable |
35.0 |
|
39.3 |
Inventories |
160.5 |
|
131.3 |
Deferred income taxes |
8.7 |
|
17.3 |
Other current assets |
12.3 |
|
7.2 |
|
------------- |
|
------------- |
Total current assets |
737.0 |
|
604.8 |
|
|
|
|
Investment in associated companies |
89.0 |
|
90.4 |
|
|
|
|
Plants, equipment and facilities, at cost |
1,438.9 |
|
1,383.4 |
Less: accumulated depreciation |
(854.0) |
|
(805.5) |
|
------------- |
|
------------- |
Net plant investment |
584.9 |
|
577.9 |
|
|
|
|
Acquisition intangibles, net of accumulated amortization |
38.2 |
|
39.5 |
|
|
|
|
Goodwill |
334.0 |
|
334.0 |
|
|
|
|
Deferred income taxes |
83.7 |
|
71.6 |
|
|
|
|
Other assets |
33.5 |
|
33.3 |
|
------------- |
|
------------- |
Total assets |
$ 1,900.3 |
|
$ 1,751.5 |
|
======== |
|
======== |
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
Current liabilities |
|
|
|
Accounts payable |
$ 101.8 |
|
$ 99.5 |
Accrued expense |
163.5 |
|
175.8 |
Current maturities of long-term debt |
- |
|
99.9 |
Income taxes payable |
56.5 |
|
55.6 |
|
------------- |
|
------------- |
Total current liabilities |
321.8 |
|
430.8 |
|
|
|
|
Long-term debt |
415.4 |
|
216.0 |
Pension and other postretirement benefit liabilities |
333.8 |
|
359.3 |
Other noncurrent liabilities |
139.9 |
|
122.5 |
Stockholders' equity |
|
|
|
Preferred stock, 20,000,000 shares authorized, |
|
|
|
Common stock, $0.1 par value per share, |
|
|
|
Additional paid-in capital |
126.0 |
|
131.1 |
Retained earnings |
946.2 |
|
905.5 |
Unearned compensation |
(6.0) |
|
(6.8) |
Minimum pension liability adjustment |
(98.0) |
|
(98.0) |
Unrealized losses on derivative instruments |
(0.1) |
|
- |
Accumulated translation adjustments |
6.3 |
|
(18.8) |
Treasury stock, at cost, |
|
|
|
|
------------- |
|
------------- |
Total stockholders' equity |
689.4 |
|
622.9 |
|
------------- |
|
------------- |
Total liabilities and stockholders' equity |
$ 1,900.3 |
|
$ 1,751.5 |
|
======== |
|
======== |
See accompanying Notes to Consolidated Financial Statements. 4
CYTEC INDUSTRIES INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(Millions of dollars)
|
Six Months Ended June 30, |
||
|
2003 |
|
2002 |
Cash flows provided by (used for) operating activities |
|
|
|
Net earnings |
$ 40.7 |
|
$ 28.4 |
Noncash items included in earnings: |
|
|
|
Dividends from associated companies greater (less) than earnings |
1.6 |
|
(2.7) |
Depreciation |
42.6 |
|
40.0 |
Amortization |
3.1 |
|
2.9 |
Deferred income taxes |
(4.0) |
|
(1.6) |
Loss on asset write-off |
- |
|
7.2 |
Gain on sale of assets |
- |
|
(1.0) |
Cumulative effect of change in accounting principle, net of tax |
13.6 |
|
- |
Other |
0.2 |
|
- |
Changes in operating assets and liabilities |
|
|
|
Trade accounts receivable |
(3.2) |
|
(26.1) |
Other receivables |
4.3 |
|
0.6 |
Inventories |
(23.5) |
|
2.8 |
Accounts payable |
0.4 |
|
2.4 |
Accrued expenses |
(14.0) |
|
26.6 |
Income taxes payable |
12.8 |
|
5.6 |
Other assets |
(4.5) |
|
(3.9) |
Other liabilities |
(34.4) |
|
(18.2) |
|
------------- |
|
------------- |
Net cash flows provided by operating activities |
35.7 |
|
63.0 |
|
------------- |
|
------------- |
Cash flows provided by (used for) investing activities |
|
|
|
Additions to plants, equipment and facilities |
(37.6) |
|
(22.6) |
Proceeds received on sale of assets |
0.1 |
|
1.0 |
|
------------- |
|
------------- |
Net cash flows used for investing activities |
(37.5) |
|
(21.6) |
|
------------- |
|
------------- |
Cash flows provided by (used for) financing activities |
|
|
|
Proceeds from the exercise of stock options |
8.3 |
|
1.9 |
Purchase of treasury stock |
(12.3) |
|
(13.1) |
Payments of long term debt |
(100.0) |
|
- |
Proceeds from long term debt |
199.1 |
|
- |
Proceeds received on sale of put options |
- |
|
0.2 |
|
------------- |
|
------------- |
Net cash flows provided by (used for) financing activities |
95.1 |
|
(11.0) |
|
------------- |
|
------------- |
Effect of exchange rate changes on cash and cash equivalents |
5.9 |
|
2.9 |
|
------------- |
|
------------- |
Increase in cash and cash equivalents |
99.2 |
|
33.3 |
|
|
|
|
Cash and cash equivalents, beginning of period |
210.0 |
|
83.6 |
|
------------- |
|
------------- |
Cash and cash equivalents, end of period |
$ 309.2 |
|
$ 116.9 |
|
======== |
|
======== |
See accompanying Notes to Consolidated Financial Statements.
5
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(Millions of dollars, except per share amounts, unless otherwise indicated)
(1) Basis of Presentation
The unaudited consolidated financial statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission for reporting on Form 10-Q. Certain information and footnote disclosures normally included in
financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. The statements should be read in conjunction with the consolidated
financial statements and notes to the consolidated financial statements contained in the Company's 2002 Annual Report on Form 10-K.
Certain reclassifications have been made to the prior year's financial statements in order to conform to the current year's presentation.
(2) Earnings Per Share (EPS)
Basic earnings per common share excludes dilution and is computed by dividing net earnings less preferred stock dividends by the weighted-average number of common shares outstanding (which includes shares outstanding, less performance and restricted shares for which
vesting criteria have not been met) plus deferred stock awards, weighted for the period outstanding. Diluted earnings per common share is computed by dividing net earnings less preferred stock dividends by the sum of the weighted-average number of common shares
outstanding for the period increased for all additional common shares that would have been outstanding if potentially dilutive common shares had been issued and any proceeds of the issuance had been used to repurchase common stock at the average market price during
the period. The proceeds used to repurchase common stock are assumed to be the sum of the amount to be paid to the Company upon exercise of options, the amount of compensation cost attributed to future services and not yet recognized and the amount of income taxes
that would be credited to or deducted from capital upon exercise.
6
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(Millions of dollars, except per share amounts, unless otherwise indicated)
The following represents the reconciliation of the numerators and denominators of the basic and diluted EPS computations:
|
Three Months Ended June 30, |
||||||
|
2003 |
|
2002 |
||||
|
|
Weighted Avg. |
Per |
|
|
Weighted Avg. |
Per |
|
|
|
|
|
|
|
|
Basic EPS |
|
38,828,834 |
|
|
|
39,623,876 |
|
Net earnings |
$25.4 |
|
$0.65 |
|
$21.4 |
|
$0.54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS |
|
|
|
|
|
|
|
Effect of dilutive securities |
|
|
|
|
|
|
|
Options |
|
1,051,093 |
|
|
|
1,159,641 |
|
Performance / Restricted stock |
|
110,245 |
|
|
|
103,214 |
|
|
|
|
|
|
|
|
|
Weighted average shares |
|
39,990,172 |
|
|
|
40,886,731 |
|
Net earnings |
$25.4 |
|
$0.64 |
|
$21.4 |
|
$0.52 |
|
|
|
|
|
|
|
|
-------------------------------------------------------------------------------------------------------------------------------------------------------
|
Six Months Ended June 30, |
||||||
|
2003 |
|
2002 |
||||
|
|
Weighted Avg. |
Per |
|
|
Weighted Avg. |
Per |
|
|
|
|
|
|
|
|
Basic EPS |
|
38,782,148 |
|
|
|
39,663,454 |
|
Earnings before cumulative effect of |
$54.3 |
|
$1.40 |
|
|
|
|
Cumulative effect of accounting change |
(13.6) |
(0.35) |
- |
|
- |
||
|
-------- |
|
-------- |
|
-------- |
|
-------- |
Net earnings |
$40.7 |
|
$1.05 |
|
$28.4 |
|
$0.72 |
|
|
|
|
|
|
|
|
Diluted EPS |
|
|
|
|
|
|
|
Effect of dilutive securities |
|
|
|
|
|
|
|
Options |
|
981,848 |
|
|
|
1,012,330 |
|
Performance / Restricted stock |
|
113,527 |
|
|
|
98,128 |
|
Warrants |
|
- |
|
|
|
1,250 |
|
|
|
-------------- |
|
|
|
-------------- |
|
Weighted average shares |
|
39,877,523 |
|
|
|
40,775,162 |
|
Earnings before cumulative effect of |
$54.3 |
|
$1.36 |
|
|
|
|
Cumulative effect of accounting change |
(13.6) |
(0.34) |
- |
|
- |
||
|
-------- |
|
-------- |
|
-------- |
|
-------- |
Net earnings |
$40.7 |
|
$1.02 |
|
$28.4 |
|
$0.70 |
|
|
|
|
|
|
|
|
(3) Stock-Based Compensation
The Company accounts for its stock based compensation under the recognition and measurement principles of Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees," and related Interpretations. No stock-based compensation cost is
reflected in net income for stock options, as all options granted under those plans had an exercise price equal to the market value of the underlying common stock on the date of the grant. Compensation cost for restricted stock is recorded based on the market
value on the date of grant, and compensation cost for performance stock is recorded based on the quoted market price of the Company's common stock at the end of each period through the date of vesting. The fair value of restricted and performance stock is
charged to unearned compensation in Stockholders' Equity and amortized to expense over the requisite vesting periods.
7
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(Millions of dollars, except per share amounts, unless otherwise indicated)
The following table illustrates the effect on net income and earnings per share if the Company had applied the fair value recognition provisions of SFAS No. 123, “Accounting for Stock-Based Compensation” to stock-based employee compensation:
|
Three Months Ended |
|
Six Months Ended |
||||
|
2003 |
|
2002 |
|
2003 |
|
2002 |
|
|
|
|
|
|
|
|
Net earnings, as reported |
$ 25.4 |
|
$ 21.4 |
|
$ 40.7 |
|
$ 28.4 |
Add: |
|
|
|
|
|
|
|
Stock-based employee compensation expense included |
|
|
|
|
|
|
|
Deduct: |
|
|
|
|
|
|
|
Total stock-based employee compensation expense |
|
|
|
|
|
|
|
|
----------- |
|
----------- |
|
----------- |
|
----------- |
Pro forma net earnings |
$ 23.9 |
|
$ 19.3 |
|
$ 37.3 |
|
$ 24.5 |
|
====== |
|
====== |
|
====== |
|
====== |
Earnings per share: |
|
|
|
|
|
|
|
Basic, as reported |
$ 0.65 |
|
$ 0.54 |
|
$ 1.05 |
|
$ 0.72 |
Basic, pro forma |
0.62 |
|
0.49 |
|
0.96 |
|
0.62 |
Diluted, as reported |
$ 0.64 |
|
$ 0.52 |
|
$ 1.02 |
|
$ 0.70 |
Diluted, pro forma |
0.60 |
|
0.47 |
|
0.94 |
|
0.60 |
The weighted average fair value at the date of grant for options granted in 2003 and 2002 was $12.56 per option and $11.65 per option, respectively. The fair value of each grant is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:
|
2003 |
|
2002 |
|
|
|
|
Expected life (years) |
5.6 |
|
5.6 |
Expected volatility |
47.3% |
|
47.4% |
Expected dividend yield |
- |
|
- |
Risk-free interest rate |
2.9% |
|
3.3% |
(4) Recently Issued Statements of Financial Accounting Standards
On January 1, 2003, the Company adopted SFAS No. 143, "Accounting for Asset Retirement Obligations" ("SFAS 143"). SFAS 143 addresses the financial accounting and reporting for obligations associated with the retirement of tangible long-lived assets and the
associated asset retirement costs. The standard applies to legal obligations associated with the retirement of long-lived assets that result from the acquisition, construction, development and/or normal use of an asset. SFAS 143 requires that the fair value of
the liability for an asset retirement obligation be recognized in the period in which it is incurred if a reasonable estimate of fair value can be made. The fair value of the liability is added to the carrying amount of the associated asset and this additional
carrying amount is depreciated over the life of the asset. The liability is accreted at the end of each period through charges to operating expense. If the obligation is settled for other than the carrying amount of the liability the Company will recognize a gain or
loss on settlement.
On January 1, 2003, the Company recorded an increase in long-term liabilities of $22.8, an increase in the gross carrying value of Plants, Equipment and Facilities of $5.3 and related accumulated depreciation of approximately $3.4, a long-term deferred tax asset of
$7.3 and an after-tax charge of $13.6 for the cumulative effect of prior years for depreciation of the additional costs and accretion expense on the asset retirement liability. The long-term liability relates primarily to estimated costs for disposal of
building materials and other closure obligations for existing structures upon renovation, closure or dismantlement of
8
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(Millions of dollars, except per share amounts, unless otherwise indicated)
certainof the Company’s facilities. At June 30, 2003, the asset retirement liability was $22.9. Accretion and depreciation expense for the three and six months ended June 30, 2003 were $0.5 and $0.9, respectively. The pro forma amount of the asset retirement liability as of June 30, 2002, was $22.0. The pro forma amounts of the asset retirement liability were measured using information, assumptions and interest rates as of the adoption date of January 1, 2003. Pro forma net earnings and earnings per share for the three and six months ended June 30, 2002, assuming SFAS 143 had been applied as of January 1, 2002, are as follows:
|
Net |
Basic |
Diluted |
Three months ended June 30, 2002 |
|
|
|
|
|
|
|
As Reported |
$21.4 |
$0.54 |
$0.52 |
|
|
|
|
Pro forma amounts |
$21.2 |
$0.53 |
$0.51 |
|
|
|
|
Six months ended June 30, 2002 |
|
|
|
|
|
|
|
As Reported |
$28.4 |
$0.72 |
$0.70 |
|
|
|
|
Pro forma amounts |
$27.9 |
$0.70 |
$0.68 |
(5) Inventories
The inventories consisted of the following:
|
June 30, |
|
December 31, |
|
|
||
|
|
|
|
Finished goods |
$ 97.5 |
|
$ 81.4 |
Work in process |
22.3 |
|
15.1 |
Raw materials & supplies |
71.4 |
|
65.5 |
|
------------ |
|
------------ |
|
191.2 |
|
162.0 |
Less reduction to LIFO cost |
(30.7) |
|
(30.7) |
|
------------ |
|
------------ |
|
$ 160.5 |
|
$ 131.3 |
|
======= |
|
======= |
9
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(Millions of dollars, except per share amounts, unless otherwise indicated)
(6) Equity in Earnings of Associated Companies
Summarized financial information for the Company's equity in earnings of associated companies is as follows:
|
|
Three Months Ended |
|
Six Months |
|||
|
|
2003 |
2002 |
|
2003 |
2002 |
|
|
|
|
|
|
|
|
|
Net sales |
|
$81.8 |
$82.2 |
|
$165.2 |
$153.3 |
|
Gross profit |
|
12.6 |
15.5 |
|
28.2 |
29.6 |
|
Earnings before cumulative effect of change in accounting principle |
|
|
|
|
|
|
|
Cumulative effect of adoption of SFAS 143, net of tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings |
|
1.3 |
3.9 |
|
5.6 |
6.1 |
|
|
|
|
|
|
|
|
|
The Company's equity in earnings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company's equity in cumulative effect of adoption of SFAS 143, net of tax, of associated companies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(Millions of dollars, except per share amounts, unless otherwise indicated)
(7) Long-Term Debt
In March 2003, the Company repaid the $100.0 current maturity of its long-term debt. On June 24, 2003, the Company sold $200.0 principal amount of 4.60% Notes due July 1, 2013. The securities were offered under the Company’s $400.0 shelf
registration statement. The Company received approximately $198.5 in proceeds from the sale after deducting costs associated with the sale. The proceeds are intended to be used for general corporate purposes, which may include acquisitions of product
lines and technologies (including the acquisition of Avecia Investments Limited’s Metal Extractant Products and Intermediates & Stabilizers businesses) and additional funding of certain benefit plans of the Company.
In April 2002, the Company executed a $100.0, three-year unsecured revolving credit agreement and a $100.0, 364-day unsecured revolving credit agreement with a one-year term out option which was renewed in April 2003. Revolving loans under the agreements are
available for the general corporate purposes of the Company and its subsidiaries, including without limitation, for purposes of making acquisitions. The credit agreements contain covenants customary for such facilities.
(8) Environmental Matters and Other Contingent Liabilities
As of June 30, 2003, and December 31, 2002, the aggregate environmental related accruals were $82.5 and $83.7, respectively. As of June 30, 2003, and December 31, 2002, $15.0 of the above amounts were included in accrued expenses, with the remainder
included in other noncurrent liabilities. Environmental remediation spending for the six months ended June 30, 2003 and 2002, was $3.5 and $6.2, respectively. All accruals have been recorded without giving effect to any possible future insurance
proceeds.
The Company is also a party to various other claims and litigation. Based on the advice of counsel, management believes that the resolution of such claims and litigation will not have a material adverse effect on the consolidated financial position of the Company,
but could be material to the consolidated results of operations of the Company in any one accounting period.
11
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(Millions of dollars, except per share amounts, unless otherwise indicated)
(9) Comprehensive Income
The components of comprehensive income, which represents the change in equity from non-owner sources, are as follows:
|
|
Three Months Ended |
|
Six Months Ended |
||||
|
|
2003 |
|
2002 |
|
2003 |
|
2002 |
|
|
|
|
|
|
|
|
|
Net earnings |
|
$25.4 |
|
$21.4 |
|
$40.7 |
|
$28.4 |
Other comprehensive income: |
|
|
|
|
|
|
|
|
Unrealized gains (losses) on derivative |
|
|
|
|
|
|
|
|
Foreign currency translation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
$45.1 |
|
$41.3 |
|
$65.7 |
|
$45.4 |
|
|
====== |
|
====== |
|
====== |
|
====== |
(10) Other Financial Information
Taxes paid for the six months ended June 30, 2003 and 2002, were approximately $9.9 and $7.0, respectively. Interest paid for the six months ended June 30, 2003 and 2002 was approximately $10.7 in both periods.
In March 2003, the Company announced an authorization of $100.0 to repurchase shares of its outstanding common stock. The repurchases are made from time to time on the open market or in private transactions and the shares obtained under this authorization are
anticipated to be utilized for stock option plans, benefit plans and other corporate purposes. Through June 30, 2003 the Company repurchased 414,100 shares of stock at a cost of $12.3 that completed its previous authorization and that included the purchase of
approximately 87,600 shares under this new authorization.
12
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(Millions of dollars, except per share amounts, unless otherwise indicated)
(11) Segment Information
Summarized segment information follows:
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
||
|
|
|
|
|
|
|
2003 |
2002 |
|
2003 |
2002 |
|
|
|
|
|
|
Net sales |
|
|
|
|
|
|
|
|
|
|
|
Water and Industrial Process Chemicals |
$ 89.2 |
$ 83.6 |
|
$ 174.9 |
$ 159.2 |
Performance Products |
123.2 |
117.7 |
|
242.9 |
226.2 |
Specialty Materials |
107.9 |
103.4 |
|
216.1 |
206.5 |
Building Block Chemicals |
|
|
|
|
|
Sales to external customers |
54.6 |
46.2 |
|
108.3 |
77.0 |
Intersegment sales |
18.0 |
14.1 |
|
34.4 |
25.7 |
|
---------- |
---------- |
|
---------- |
---------- |
Net sales from segments |
392.9 |
365.0 |
|
776.6 |
694.6 |
Elimination of intersegment revenue |
(18.0) |
(14.1) |
|
(34.4) |
(25.7) |
|
---------- |
---------- |
|
---------- |
---------- |
Total consolidated net sales |
$ 374.9 |
$ 350.9 |
|
$ 742.2 |
$ 668.9 |
|
====== |
====== |
|
====== |
====== |
|
|
% of |
|
% of |
|
|
% of |
|
% of |
|
|
|
|
|
|
|
|
|
|
Water and Industrial Process Chemicals |
$ 3.7 |
4% |
$ 4.9 |
6% |
|
$ 10.6 |
6% |
$ 10.3 |
6% |
Performance Products |
10.9 |
9% |
13.4 |
11% |
|
22.7 |
9% |
20.0 |
9% |
Specialty Materials |
20.0 |
19% |
18.3 |
18% |
|
42.3 |
20% |
38.8 |
19% |
Building Block Chemicals |
8.4 |
12% |
(0.8) |
-1% |
|
12.7 |
9% |
(1.3) |
-1% |
|
------ |
|
------ |
|
|
----- |
|
------ |
|
Earnings from segments |
43.0 |
11% |
35.8 |
10% |
|
88.3 |
11% |
67.8 |
10% |
|
|
|
|
|
|
|
|
|
|
Corporate and Unallocated (1) |
(1.7) |
|
(1.2) |
|
|
(2.9) |
|
(17.8) |
|
|
------ |
|
------ |
|
|
----- |
|
------ |
|
Total consolidated earnings from operations |
$ 41.3 |
11% |
$ 34.6 |
10% |
|
$ 85.4 |
12% |
$ 50.0 |
7% |
|
==== |
|
==== |
|
|
==== |
|
==== |
|
(1) Six months ended June 30, 2002 includes net restructuring charges of $14.8. (See Note 13).
(12) Other Acquisition Intangibles
Other acquisition intangibles consisted of the following major classes at June 30, 2003:
|
Gross |
|
Accumulated |
|
Acquisition |
|
|
|
|
|
|
Technology-based |
$ 30.0 |
|
$ (7.8) |
|
$22.2 |
Marketing-related |
9.7 |
|
(2.5) |
|
7.2 |
Customer-related |
11.9 |
|
(3.1) |
|
8.8 |
|
---------- |
|
---------- |
|
---------- |
Total |
$ 51.6 |
|
$(13.4) |
|
$38.2 |
|
====== |
|
====== |
|
====== |
Amortization of acquisition intangibles for the three and six months ended June 30, 2003, was $0.8 and $1.6, respectively. Assuming no change in the gross carrying amount of acquisition intangibles, the estimated amortization of acquisition intangibles for the fiscal years 2003 through 2005 is $3.1 and for the years 2006 and 2007 is $3.0. At June 30, 2003, there were no acquisition intangibles with indefinite useful lives as defined by SFAS 142.
13
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(Millions of dollars, except per share amounts, unless otherwise indicated)
(13) Restructuring of Operations
In the first quarter of 2002, the Company recorded an aggregate restructuring charge of $16.6, which included the elimination of 135 positions worldwide. The charge was comprised of the following initiatives: reorganization of
the Specialty Chemicals segments resulting in a reduction of 65 personnel and a charge of $5.7 for employee related costs; alignment of the Specialty Materials segment in connection with reduced demand in the commercial aerospace industry resulting in a reduction of
47 personnel and a charge of $1.6 for employee related costs; closure of the Woodbridge, New Jersey facility resulting in the elimination of 23 positions and a charge of $1.6 for employee related and decommissioning costs and the discontinuance of a minor
unprofitable product line resulting in a charge of $7.7 for the write-down of the net book value of the fixed assets and costs of decommissioning the facility. The restructuring costs were charged to the Consolidated Statements of Income as follows: manufacturing
cost of sales, $11.7; selling and technical services, $3.0; research and process development, $1.0 and administrative and general, $0.9. During the fourth quarter of 2002, the Company reduced this restructuring accrual as a result of incurring less costs than
originally estimated. As a result, the Company recognized a restructuring credit of $0.6 in the Consolidated Statement of Income as follows: manufacturing cost of sales, $0.1; selling and technical services, $0.4; and administrative and general,
$0.1. As of June 30, 2003, cash payments of $7.0 had been made for these charges and the remaining liability to be paid was $1.8. The Company expects that the majority of this liability will be paid in the remainder of 2003. In addition, during the
first quarter of 2002 the Company recorded charges of $0.4 in equity in earnings of associated companies for its 50% share of additional restructuring charges related to CYRO Industries' shutdown of its Niagara Falls, Ontario, Canada facility.
In 2001, the Company recorded a restructuring charge of $5.4 related to the mothballing of the Fortier ammonia plant and the Company's share of the related personnel reduction of 67 positions at the Fortier facility. During the first
quarter of 2002, the Company reduced this restructuring accrual as a result of incurring fewer costs than originally estimated. As a result, the Company recognized a restructuring credit of $0.5 in the Consolidated Statements of Income as follows: manufacturing
cost of sales, $0.4 and selling and technical services, $0.1. This restructuring accrual was further reduced by $0.4 in the fourth quarter of 2002 as a credit to manufacturing cost of sales. The personnel reductions were completed in 2002. Cash
payments of $3.6 had been made for these charges through June 30, 2003 that completed this restructuring.
In 2000, the Company recorded a restructuring charge of $10.8 related to a workforce reduction of approximately 110 employees and the discontinuance of a tolling operation. During the first quarter of 2002, the Company reduced this restructuring accrual as a
result of incurring fewer costs than originally estimated. As a result, the Company recognized a restructuring credit of $1.3 in the Consolidated Statements of Income as follows: manufacturing cost of sales, $0.5 and selling and technical services, $0.8.
This restructuring accrual was further reduced by $0.1 in the fourth quarter of 2002 as a credit to selling and technical services. The personnel reductions were completed in 2002. Cash payments of $7.4 had been made for these charges through June 30,
2003 that completed this restructuring.
(14) Commodity and Derivative Financial Instruments
The Company uses natural gas forward contracts to selectively hedge natural gas utility requirements at its Building Block Chemicals Fortier manufacturing facility. Realized gains and losses on these contracts, if any, are included in the cost of the commodity
upon settlement of the contract. As of June 30, 2003, the Fortier facility's 2003 remaining forecasted natural gas utility requirements were approximately 80% hedged at an approximate price of $5.40 and the 2004 forecasted natural gas utility requirements were
approximately 20%
14
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(Millions of dollars, except per share amounts, unless otherwise indicated)
hedged at an approximate price of $5.60. These amounts exclude taxes and transportation costs. At June 30, 2003, the Company had outstanding natural gas forward contracts with a notional
value of $24.7 and delivery dates of July 2003 through June 2004.
The Company also uses natural gas swaps to selectively hedge gas utility requirements at certain of its other facilities. These swaps, which are financially settled, are highly effective at achieving offsetting cash flows of the underlying natural gas
purchases and have been designated as cash flow hedges as defined by SFAS No. 133, "Accounting for Derivative Instruments and Hedging Activities." The swaps are reported on the Consolidated Balance Sheets at fair value, with offsetting amounts included in
Unrealized Gain (Loss) on Derivative Instruments on an after-tax basis. Gains and losses are reclassified into earnings, as a component of Manufacturing Cost of Sales in the period the hedged natural gas purchases affect earnings. As of June 30, 2003, a
loss of $0.3 related to outstanding natural gas support is included in Unrealized Gain (Loss) on Derivative Instruments.
In June 2003, the Company entered into forward currency contracts to sell Euros and buy dollars to hedge $4.0 of anticipated U.S. Dollar based inventory purchases in Europe. As of June 30, 2003, a gain of $0.2 related to these forward contracts is included in
Unrealized Gain (Loss) on Derivative Instruments.
In connection with the Company’s stock repurchase program, the Company selectively utilizes freestanding put option contracts that are indexed to the Company’s stock and entitle the holder to sell shares of the Company’s common stock to the Company
at specified exercise prices. In lieu of purchasing the shares from the put option holders, the Company has the right to elect settlement by paying the holders of the put options the excess of the strike price over the then market price of the shares in either cash
or shares of the Company’s common stock (i.e., net cash or net share settlement). The put option contracts are initially measured at fair value and reported in Stockholders’ Equity. Subsequent changes in fair value are not recognized in the financial
statements. During 2002 the Company sold 100,000 put options to an institutional investor in a private placement. The put options entitled the holder to sell an aggregate of 100,000 shares of the Company's common stock to the Company at an exercise price of $29.505
per share. During 2002, the Company received aggregate premiums of approximately $0.3 on the sale of such options. During the first quarter of 2003, the holder elected to exercise the 100,000 put options, which were settled by the Company purchasing 100,000
shares of its common stock at the exercise price of $29.505 per share. The closing stock price on the settlement date was $27.98 per share. At June 30, 2003, no put options were outstanding.
15
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Results of Operations
Second Quarter of 2003 versus Second Quarter of 2002
Net sales for the second quarter of 2003 were $374.9 compared with $350.9 for the second quarter of 2002. All segments reported increased sales. In the Specialty Chemical segments much of the increase was due to favorable exchange rate changes.
Specialty Material sales were higher primarily from increased sales to military applications. Building Block Chemical sales were up primarily due to higher selling prices for acrylonitrile.
Manufacturing cost of sales were $279.0 or 74.4% of net sales in the second quarter of 2003 compared to $263.9 or 75.2% of net sales for the prior year period. The improvement in manufacturing cost as a percent of net sales is attributable to improved plant
operations and capacity utilization, the net effect of exchange rate changes and higher selling prices for acrylonitrile. These improvements were partially offset by significantly higher raw material and energy costs, particularly from petroleum and natural gas
based products, higher freight costs from freight surcharges applied by carriers to cover the higher cost of fuel and increases in employee benefit and insurance costs.
Selling and Technical Services increased $1.2 and Research and Process Development increased $0.5 as the Company added selective resources to pursue its growth initiatives plus the unfavorable effect of exchange rate changes from a weaker U.S. dollar.
Administrative and general expenses increased $0.5, much of this due to unfavorable exchange rate changes from the weak U.S. dollar. In addition increased expenses for the Company’s performance stock plan were incurred as a result of the mark to market
accounting based on the Company’s higher stock price at the end of the quarter.
Other expense, net increased $2.8 from the year ago period resulting primarily from exchange losses where certain of our international subsidiaries held dollar denominated assets when the U.S. dollar weakened, plus cleanup costs at an operating site related to a long
since discontinued business. The prior year also included some small gains from sales of real estate.
Equity in earnings of associated companies was down $1.6 from the year ago period. This was due to lower earnings at CYRO Industries, our 50% owned acrylic plastic joint venture. Sales at CYRO were up but the benefit of this was more than offset by an
unfavorable product mix plus increased raw material and energy costs.
Interest expense, net, was $3.0 a decrease of $1.9 from the prior year period. This was due to higher cash balances and the repayment in March 2003 of $100.0 of debt with an interest rate of 6.5% per annum resulting in lower interest expense for the
quarter.
The income tax provision reflects an effective tax rate of 30.0% down from the prior year’s 33.5%. This reduction was a result of the Company’s emphasis on global tax planning and execution of, those plans together with an increased level of
investment and earnings in lower foreign tax jurisdictions.
Net earnings were $25.4 or $0.64 per diluted share in the second quarter of 2003 compared to $21.4 or $0.52 per diluted share in the second quarter of 2002.
16
Segment Results
Second quarter 2003 to second quarter 2002 comparisons and analyses of changes in net sales by business segment and region are set forth below.
Water and Industrial Process Chemicals:
------------------------------------------------------------------------------------------------------------------------------
|
Second |
Second |
|
|
||
|
Price |
Volume/Mix |
Exchange |
|||
North America |
$35.2 |
$36.6 |
-4% |
-3% |
-1% |
0% |
Latin America |
14.2 |
12.9 |
10% |
4% |
12% |
-6% |
Asia/Pacific Rim |
13.4 |
10.5 |
27% |
-5% |
27% |
5% |
Europe/Middle East/Africa |
26.4 |
23.6 |
12% |
-3% |
1% |
14% |
Total |
$89.2 |
$83.6 |
7% |
-2% |
5% |
4% |
------------------------------------------------------------------------------------------------------------------------------
Selling volumes improved in all product lines and overall by 5%. North American volumes were down slightly primarily in phosphines due to order pattern. In Latin America volumes were up primarily in mining
chemicals from higher demand in the alumina market. Asia-Pacific volumes were up principally in phosphines due to continued sales from our new solvent extractant product for nickel-cobalt mining. European selling volume was up slightly with mining having
increased demand from copper markets offset by lower phosphine demand from the nickel-cobalt market. Selling prices in North America and Europe were down primarily due to customer mix. In Latin America selling prices were up offsetting the impact of
negative exchange rate changes. In Asia-Pacific, prices were down principally in mining chemicals where pricing is linked to the U.S. dollar thus reflecting the effect of exchange rate changes.
Earnings from operations were $3.7 or 4% of sales in the second quarter of 2003 versus $4.9 or 6% of sales in the comparable period of 2002. The benefit of the increased sales was more than offset by higher raw material and energy, employee benefit and
insurance costs.
Performance Products:
------------------------------------------------------------------------------------------------------------------------------
|
Second |
Second |
|
|
||
|
Price |
Volume/Mix |
Exchange |
|||
North America |
$61.7 |
$62.8 |
-2% |
2% |
-4% |
0% |
Latin America |
6.9 |
6.2 |
11% |
8% |
12% |
-9% |
Asia/Pacific Rim |
20.7 |
18.9 |
9% |
-2% |
9% |
2% |
Europe/Middle East/Africa |
33.9 |
29.8 |
14% |
2% |
-6% |
18% |
Total |
$123.2 |
$117.7 |
5% |
2% |
-2% |
5% |
------------------------------------------------------------------------------------------------------------------------------
Selling volumes overall decreased 2% with lower demand in the North American and European markets for coatings and polymer additives. Latin America and Asia-Pacific volumes increased principally in the coating and
polymer additives product lines due to new business. Selling prices were up in all product lines except polymer additives. There is still significant price pressure in polymer additives in Asia and North America although the rate of decline has
lessened.
Earnings from operations were $10.9 or 9% of sales in the second quarter of 2003 versus $13.4 or 11% of sales in the comparable period of 2002. The benefit of the increased sales was more than offset by higher raw material and energy, employee benefit and
insurance costs.
17
Specialty Materials:
------------------------------------------------------------------------------------------------------------------------------
|
Second |
Second |
|
|
||
|
Price |
Volume/Mix |
Exchange |
|||
North America |
$79.0 |
$76.9 |
3% |
0% |
3% |
0% |
Latin America (1) |
0.4 |
0.4 |
- |
- |
- |
- |
Asia/Pacific Rim |
4.3 |
4.0 |
8% |
-3% |
11% |
0% |
Europe/Middle East/Africa |
24.2 |
22.1 |
10% |
-2% |
8% |
4% |
Total |
$107.9 |
$103.4 |
4% |
-1% |
4% |
1% |
------------------------------------------------------------------------------------------------------------------------------
Due to the level of sales in this geographic region, percentage comparisons are not meaningful.
Selling volumes overall were up 4% as a result of strong demand from the military sector while sales to the large commercial aircraft sector were flat and sales to the business and regional jet sector were down.
Earnings from operations were $20 or 19% of sales in the second quarter of 2003 versus $18.3 or 18% of sales in the comparable period of 2002. The improvement was due to the increased sales partially offset by higher employee benefit and insurance costs.
Building Block Chemicals:
------------------------------------------------------------------------------------------------------------------------------
|
Second |
Second |
|
|
||
|
Price |
Volume/Mix |
Exchange |
|||
North America |
$24.6 |
$16.1 |
52% |
30% |
22% |
0% |
Latin America (1) |
1.1 |
1.0 |
- |
- |
- |
- |
Asia/Pacific Rim |
16.4 |
21.5 |
-24% |
29% |
-53% |
0% |
Europe/Middle East/Africa |
12.5 |
7.6 |
65% |
10% |
34% |
21% |
Total |
$54.6 |
$46.2 |
18% |
26% |
-11% |
3% |
------------------------------------------------------------------------------------------------------------------------------
(1) Due to the level of sales in this geographic region, percentage comparisons are not meaningful.
Selling volumes overall decreased 11% overall and principally in Asia-Pacific where demand for acrylonitrile was low. Partially offsetting the lower selling volumes in Asia-Pacific were increases for acrylonitrile in Europe and North America due principally to
new business. Selling prices were up significantly primarily related to acrylonitrile as prices were up due to tighter supply and increased input costs.
Earnings from operations were $8.4 or 12% of sales in the second quarter of 2003 versus a loss of $0.8 in the comparable period of 2002. Earnings benefited from the increased selling prices and improved manufacturing operations and capacity utilization.
These more than offset the higher raw material and energy costs, primarily ammonia, propylene and natural gas, and increases in employee benefit and insurance costs.
First Six Months of 2003 versus First Six Months of 2002
Net sales for the first six months of 2003 were $742.2 compared with $668.9 for the prior year period. All segments reported increased sales. In the Specialty Chemical segments, much of the increase was due to favorable exchange rate changes and
higher selling volumes in the Water and Industrial Process segment. In Specialty Materials, sales were higher primarily from increased sales to military applications, a high level of replacement part purchases for rotorcraft and what is believed to be inventory
rebuilding by certain customers from low year end levels. Building Block Chemical sales were up primarily due to higher selling prices and volumes for acrylonitrile.
18
Manufacturing cost of sales were $551.4 or 74.3% of net sales in the first six months of 2003 compared to $511.8 or 76.5% of net sales for the prior year period. Included in the first six months of 2002 is a $10.8 net
restructuring charge or 1.6% of net sales for plant closure costs and expenses associated with discontinuing a product line. The improvement in manufacturing cost as a percent of net sales in the first six months of 2003 versus the prior year period is
attributable to the restructuring charges recorded in 2002, improved plant operations and capacity utilization, the net effect of exchange rate changes and higher selling prices for acrylonitrile. These improvements were partially offset by significantly higher
raw material and energy costs, particularly from petroleum and natural gas based products, higher freight costs from freight surcharges applied by carriers to cover the higher cost of fuel and increases in employee benefit and insurance costs.
Selling and Technical Services decreased $0.6, Research and Process Development decreased $0.2 and Administrative expenses decreased $0.9 but included in prior year amounts are net restructuring charges of $2.1, $1.0 and $0.9 respectively. After exclusion of
the restructuring charges Selling and Technical Services increased $1.5, Research and Process Development increased $0.8 and Administrative and general expenses were flat. The increases in costs reflect the Company’s focus on its growth initiatives.
In addition, overall operating costs were higher due to unfavorable exchange rate changes from a weaker U.S. dollar.
Other expense, net increased $3.1 from the year ago period resulting primarily from exchange losses where certain of our international subsidiaries held dollar denominated assets when the U.S. dollar weakened, plus cleanup costs at an operating site related to a
long since discontinued business. The prior year also included some small gains from sales of real estate.
Equity in earnings of associated companies were down $0.2 from the year ago period. This was due to lower earnings at CYRO Industries, our 50% owned acrylic plastic joint venture. Sales at CYRO were up 7% but this benefit was more than offset by an
unfavorable product mix plus significantly increased raw material and energy costs. Included in 2002 results was a restructuring charge of $0.4 representing the Company’s 50% share of restructuring charges recorded by CYRO.
Interest expense, net was $7.2 a decrease of $2.8 from the prior year period. This was due to higher cash balances outstanding and in March 2003 the Company repaid $100 of its existing debt with an interest rate of 6.5% per annum resulting in lower interest
expense.
The income tax provision reflects an effective tax rate of 30.0% down from the prior years 33.5%. This reduction was a result of the Company’s emphasis on global tax planning and execution of those plans together with an increased level of investment and
earnings in lower foreign tax jurisdictions.
Net earnings before the cumulative effect of the change in accounting principle were $54.3 or $1.36 per diluted share in the first six months of 2003 versus $28.4 or $0.70 per diluted share in the comparable period of 2002. Included in
the first six months of 2002 was an after-tax net restructuring charge of $10.1 or $0.25 per diluted share.
In the first quarter of 2003, the Company recorded an after-tax, non-cash charge of $13.6 ($0.34 per diluted share) reported as a cumulative effect of a change in accounting principle. This relates to the adoption of Financial Accounting Standard No. 143 (FAS
143), “Accounting for Asset Retirement Obligations” which became effective January 1, 2003.
Net earnings after the cumulative effect of the change in accounting principle as a result of adopting FAS 143 was $40.7 or $1.02 per diluted share.
19
Segment results
First six months of 2003 to the first six months of 2002 comparisons and analyses of changes in net sales by business segment and region are set forth below.
Water and Industrial Process Chemicals:
------------------------------------------------------------------------------------------------------------------------------
|
First |
First |
|
|
||
|
Price |
Volume/Mix |
Exchange |
|||
North America |
$70.0 |
$69.7 |
0% |
-3% |
3% |
0% |
Latin America |
28.5 |
25.2 |
13% |
7% |
15% |
-9% |
Asia/Pacific Rim |
24.3 |
20.2 |
20% |
-4% |
18% |
6% |
Europe/Middle East/Africa |
52.1 |
44.1 |
18% |
-2% |
4% |
16% |
Total |
$174.9 |
$159.2 |
10% |
-1% |
7% |
4% |
------------------------------------------------------------------------------------------------------------------------------
Sales increased 10% overall. Exchange rate changes accounted for 4%, principally from the Euro offset somewhat by overall weakness in Latin American currencies. Selling volumes improved in all product lines and
overall by 7%. North American volumes were improved in Water Treatment where sales to the full service customers were higher and in phosphines which saw higher demand principally in the first quarter. In Latin America the volume growth was primarily in
the mining chemicals product line as a result of higher demand in the alumina market. Asia-Pacific volumes were up in all product lines and European growth was primarily in water treatment and mining chemicals.
Earnings from operations were $10.6 or 6% of sales in the first six months of 2003 versus $10.3 or 6% of sales in the comparable period of 2002. The benefit of the increased sales was essentially offset by higher raw material, energy, employee benefit and
insurance costs. Raw material and energy costs rose significantly in the second quarter of 2003.
Performance Products:
------------------------------------------------------------------------------------------------------------------------------
|
First |
First |
|
|
||
|
Price |
Volume/Mix |
Exchange |
|||
North America |
$123.3 |
$124.7 |
-1% |
2% |
-4% |
1% |
Latin America |
14.1 |
12.0 |
17% |
9% |
21% |
-13% |
Asia/Pacific Rim |
40.9 |
34.4 |
19% |
-2% |
18% |
3% |
Europe/Middle East/Africa |
64.6 |
55.1 |
17% |
1% |
-2% |
18% |
Total |
$242.9 |
$226.2 |
7% |
2% |
1% |
4% |
------------------------------------------------------------------------------------------------------------------------------
Sales increased 7% overall. Exchange rate changes accounted for 4%, principally from the Euro offset somewhat by overall weakness in Latin American currencies. Selling volumes overall increased 1%. Globally
volumes were up in all product lines with lower demand in the North American and European markets offset by higher demand in Latin America and Asia-Pacific. Selling prices were up in all regions except Asia-Pacific where selling prices were down in polymer
additives.
Earnings from operations were $22.7 or 9% of sales in the first six months of 2003 versus $20.0 or 9% of sales in the comparable period of 2002. The benefit of the increased sales was partially offset by higher raw material, energy, employee benefit and
insurance costs.
20
Specialty Materials:
------------------------------------------------------------------------------------------------------------------------------
|
First |
First |
|
|
||
|
Price |
Volume/Mix |
Exchange |
|||
North America |
$157.3 |
$151.8 |
4% |
-0% |
4% |
0% |
Latin America (1) |
0.9 |
0.6 |
- |
- |
- |
- |
Asia/Pacific Rim |
8.3 |
7.2 |
16% |
-4% |
20% |
0% |
Europe/Middle East/Africa |
49.5 |
47.0 |
5% |
-2% |
3% |
4% |
Total |
$216.1 |
$206.5 |
5% |
-1% |
5% |
1% |
------------------------------------------------------------------------------------------------------------------------------
(1) Due to the level of sales in this geographic region, percentage comparisons are not meaningful.
Selling volumes were up 5% overall as a result of strong sales to military applications, a high level of replacement parts for rotorcraft and restocking by certain customers from low year end inventory levels. Sales to the commercial aerospace
sector for both large commercial aircraft and business and regional jets were essentially flat versus the prior year.
Earnings from operations were $42.3 or 20% of sales in the first six months of 2003 versus $38.8 or 19% of sales in the comparable period of 2002. The improvement was due to the increased sales partially offset by higher employee benefit and insurance
costs.
Building Block Chemicals:
------------------------------------------------------------------------------------------------------------------------------
|
First |
First |
|
|
||
|
Price |
Volume/Mix |
Exchange |
|||
North America |
$45.4 |
$30.0 |
51% |
24% |
27% |
0% |
Latin America (1) |
2.6 |
1.6 |
- |
- |
- |
- |
Asia/Pacific Rim |
30.5 |
32.1 |
-5% |
25% |
-30% |
0% |
Europe/Middle East/Africa |
29.8 |
13.3 |
124% |
28% |
70% |
26% |
Total |
$108.3 |
$77.0 |
41% |
25% |
12% |
4% |
------------------------------------------------------------------------------------------------------------------------------
(1) Due to the level of sales in this geographic region, percentage comparisons are not meaningful.
Selling volumes increased 12% overall. North American and European acrylonitrile volumes were up due to new business. Demand in Asia-Pacific for acrylonitrile was low. Selling prices were up significantly primarily related to acyrlonitrile as prices were
up due to tighter supply and increased input costs.
Earnings from operations were $12.7 or 9% of sales in the first six months of 2003 versus a loss of $1.3 in the comparable period of 2002. Earnings benefited from the increased selling volumes and prices in addition to improved plant operations and capacity
utilization. This more than offset the significantly higher raw material and energy costs, primarily ammonia, propylene and natural gas.
Liquidity and Financial Condition
At June 30, 2003, the Company's cash balance was $309.2, an increase of $99.2 from year-end 2002. In March 2003, the Company repaid the $100.0 of its 6.50% Notes then due. In June 2003, the Company sold $200.0 principal amount of 4.60% Notes due
July 1, 2013.
Net cash flows provided by operating activities were $35.7 for the first six months of 2003, compared to $63.0 for the same period of 2002.
21
Accounts receivable were up slightly for the six month period due to the higher sales, but days outstanding have declined. Inventory increased in line with the higher sales volumes and due to higher capacity utilization
and certain of the Company's plants campaigning production. Accrued expenses decreased as the Company made payments of approximately $17 for incentive compensation and profit growth sharing achieved in 2002. Payments made in the same period of 2002 for
incentive compensation and profit growth sharing were minimal because most 2001 targets were not achieved. Due to good cash generation and the Company’s recent low cost borrowings, the Company accelerated $19 of its contributions to its benefit plan
trusts from the second half of 2003 into the first half of 2003 resulting in a decrease in Other Liabilities.
Net cash flows used for investing activities were $37.5 for the first six months of 2003 compared to $21.6 for the same period of 2002. The ongoing renovation of the Specialty Chemicals research facility was the main factor in the increase in capital
spending. This project will continue into 2004. For the full year 2003, the Company expects capital spending to be in a range of $90.0 to $100.0.
The Company believes that, based on its expected operating results for 2003, it will be able to fund operating cash requirements and planned capital expenditures through the end of 2003 from its internal cash generation. For further discussion of risks, see
Qualitative and Quantitative Disclosures About Market Risk and Comments on Forward Looking Statements below.
Net cash flows provided by financing activities totaled $95.1 for the first six months of 2003 compared to a net use of $11.0 for the same period of 2002. In March 2003, the Company repaid $100.0 of its 6.50% debt then due. In June 2003, the Company
sold $200.0 principal amount of 4.60% Notes due July 1, 2013. Proceeds to the Company from the sale of the notes after deducting costs were approximately $198.5. In the first six months of 2003, the Company repurchased approximately 414,100 shares of
stock at a cost of $12.3 that completed its previous stock repurchase authorization and included the purchase of approximately 87,600 shares under its new authorization. Proceeds from stock option exercises totaled $8.3 in the first six months of 2003 compared
to $1.9 for the same period of 2002. The total number of treasury shares reissued as a result of option exercises was approximately 621,800 for the first six months of 2003 compared with approximately 177,800 shares reissued for the same period in 2002.
In April 2002, the Company executed a $100.0, three-year unsecured revolving credit agreement and a $100.0, 364-day unsecured revolving credit agreement with a one-year term out option, which was renewed in April 2003. Revolving loans under the new agreements
are available for the general corporate purposes of the Company and its subsidiaries, including without limitation, for purposes of making acquisitions. The credit agreements contain covenants customary for such facilities. There are no outstanding
borrowings under these credit agreements at June 30, 2003.
OTHER
In June 2003, the Company signed a definitive agreement to acquire substantially all of the assets and liabilities of Avecia Investments Ltd.’s Metal Extractant Products and Intermediates & Stabilizers businesses for approximately $97.0 in cash.
The Company expects to complete this transaction in the third quarter.
In June 2003, the Company signed definitive agreements with Mitsui Chemicals Inc. (Mitsui) concerning the Companies’ interests in the Mitsui-Cytec joint venture. The Company expects to complete the transactions in the third quarter after which the Company
will own 100% of the joint venture’s existing coating resins business, including its manufacturing facility in Shimonoseki, Japan and certain technology rights associated with the water treatment business in most of Asia. Mitsui will own 100% of the joint
venture’s existing water treatment business including its water treatment manufacturing facility in Mobarra, Japan. The net transaction U.S. dollar equivalent cost to the Company will be a cash payment of approximately $10 and the assumption of debt of
approximately $3.
22
2003 Outlook
In April 2003 the Company revised upward its full year earnings per share guidance from approximately 5% over 2002 adjusted EPS to a 10% increase. For comparability purposes, the Company has excluded from its 2002 annual reported net earnings of $79.3 and
annual diluted earnings per share of $1.96 net restructuring charges of $9.4 after tax or $0.23 per diluted share and a net credit related to prior year research and development tax credits of $6.2 after tax or $0.15 per diluted share.
The Company is still cautious about the global economy and the continuing high levels of raw material and energy costs. However, after taking into account its results for the first six months of 2003 and its current forecasts for the second half of 2003.
The Company in July, announced that it was revising upwards its full year EPS estimate, before the cumulative effect of the change in accounting principle, to a range of $2.25-$2.35 or approximately 10%-15% over the 2002 adjusted EPS of $2.04.
The full year outlook for the individual segments as of July 2003, follows.
In the Water and Industrial Process Chemicals segment, the Company still projects sales to increase about 6% with geographical expansion and new products accounting for 3% and the favorable impact of exchange rate changes accounting for the balance. However, a
difficult selling price environment plus the headwinds of higher raw material and energy costs have lead us to revise our operating earnings to be down about 20% from 2002.
In the Performance Products segment, the Company still anticipates sales to increase about 6% with geographical expansion and new products accounting for 3% and the favorable impact of exchange rate changes accounting for the balance. However, raw materials in
this segment are more natural gas based and as a result of persistently high natural gas costs and the resulting methanol derivative cost increases, the Company expects operating earnings to be about 5% over 2002.
In Specialty Materials build rates for large commercial aircraft appear to be holding and this was confirmed by recent comments from the manufacturers. The Company expects the regional and business jet producers to bring inventory levels down to better match
production rates. Sales to the military sector are expected to continue growing. The net effect is the Company expects 2003 second half sales to be on par with the second half of 2002. As a result of all of the above the Company expects sales to
increase about 3% and earnings to be essentially flat.
In Building Block Chemicals the Company is forecasting global demand to remain flat with the first half of 2003 and for most of its plants to be run generally at capacity levels. Acrylonitrile selling prices are expected to decrease slightly in the second half
of 2003 as additional capacity from a competitor is absorbed into the marketplace. The cost of propylene, the key raw material for acyrlonitrile, is expected to decline from first half levels and end the year at approximately $0.17 per pound. Costs for
ammonia, another key raw material for Building Block Chemicals, are expected to decline somewhat from the first half although costs per ton are expected to average about $200 versus $125 for 2002. For the second half of 2003 the Company has hedged about 80% of
its natural gas requirements at an approximate price of $5.40 per MMBTU, excluding taxes and transportation costs. The net result of the above is that Building Block Chemicals 2003 full year operating earnings are expected to be in a range of $20-$25.
Earnings from associated companies are expected to be below 2002 levels as a result of an unfavorable sales product mix and higher than anticipated raw material costs.
Other expense, net will increase primarily as a result of exchange losses where certain of the Company’s international subsidiaries held dollar denominated assets and Corporate and Unallocated expenses will be up due to increased performance stock
expense.
23
Based on all of the above full year assumptions, the Company expects third quarter 2003 EPS to be in the range of $0.45-$0.50. The Company will next update the 2003 outlook when it reports its third quarter 2003
operating results. There can be no assurance sales or earnings will develop in the manner projected. Actual results may differ materially. See “Comments on Forward Looking Statements”.
Comments on Forward-Looking Statements
A number of the statements made by the Company in the Quarterly Report on Form 10-Q, or in other documents, including but not limited to the Company's Annual Report to Stockholders, its press releases and other periodic reports to the Securities and Exchange
Commission, may be regarded as "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include, among others, statements concerning the Company's (including its segments) outlook for the future, the accretiveness of acquisitions, the financial effects of divestitures, pricing trends, the effects of changes in foreign
exchange rates and forces within the industry, the completion dates of and expenditures for capital projects, expected sales growth, operational excellence strategies and their results, long-term goals of the Company and other statements of expectations, beliefs,
future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts.
All predictions as to future results contain a measure of uncertainty and, accordingly, actual results could differ materially. Among the factors that could cause a difference are: changes in global and regional economies; the financial well-being of end consumers of
the Company’s products, particularly the airline industry; changes in demand for the Company's products or in the costs and availability of its raw materials and energy; customer inventory destocking; the actions of competitors; currency and interest rate
fluctuations; technological change; the Company’s ability to renegotiate expiring long-term contracts; changes in employee relations, including possible strikes; government regulations, including those particular to the sale and manufacture of chemicals
or operation of chemical plants; government funding for those military programs that utilize the Company’s products; litigation, including its inherent uncertainty; difficulties in plant operations and materials transportation; environmental matters; the
results of and recoverability of investments in associated companies; returns on employee benefit plans assets and changes in the discount rates used to estimate employee benefit liabilities; changes in the medical cost trend rate; changes in accounting principles or
new accounting standards; war, terrorism or sabotage; epidemics; and other unforeseen circumstances. A number of these factors are discussed in this and other of the Company's filings with the Securities and Exchange Commission.
Forward–looking statements speak only as of the date of this report and the Company assumes no duty or obligation to update any forward-looking statements as a result of new information or future events or developments.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
For a discussion of market risks at year-end, refer to Item 7A of the Company's 2002 Annual Report on Form 10-K for the year ended December 31, 2002, filed with the Securities and Exchange Commission on February 21, 2003. During 2003, the Company executed
various foreign exchange transactions that do not materially alter the market risk assessment performed as of December 31, 2002. Other 2003 financial instrument transactions include:
Commodity Price Risk: The Company uses natural gas forward contracts to selectively hedge gas utility requirements at its Building Blocks Chemicals Fortier manufacturing facility. These contracts typically correlate highly to the actual purchases of the
commodity and have the effect of securing predetermined prices that the Company pays for the underlying commodity. While these contracts are primarily structured to limit the Company's exposure to increases in commodity prices, they can also limit the potential
benefit the Company might have otherwise received from decreases in commodity prices. The Company also uses natural gas swaps to selectively hedge utility requirements at certain of its other facilities.
24
At June 30, 2003, the Company had outstanding natural gas forward contracts with a notional value of $24.7 and delivery dates of July 2003 through June 2004 and outstanding natural gas swaps with a fair value loss of $0.3,
which will be reclassified into Manufacturing Cost of Sales through June 2004 as these swaps are settled.
Interest Rate Risk: In March 2003 the Company repaid $100.0 of its outstanding borrowings.In June 2003, the Company sold $200.0 principal amount of 4.60% Notes due July 1, 2013. At June 30,
2003, the outstanding borrowings of the Company consisted of fixed rate long-term debt, which had a carrying value of $415.4, a face value of $420.0 and a fair value, based on dealer quoted values, of approximately $445.0. Assuming other factors are held
constant, interest rate changes generally affect the fair value of debt, but do not impact the carrying value, earnings or cash flows. Accordingly, assuming a hypothetical increase of 1% in interest rates and all other variables remaining constant, interest
expense would not change; however, the fair market value of the fixed rate long-term debt would decrease by approximately $22.1, but this change would not impact the carrying value.
Equity Price Risk: At December 31, 2002, the Company had 100,000 put options outstanding which entitled the holders to sell an aggregate of 100,000 shares of the Company's common stock to the Company at an exercise price of $29.505 per share.
During 2002, the Company received aggregate premiums of approximately $0.3 on the sale of such options. During the first quarter of 2003, the holder elected to exercise the 100,000 put options, which were settled by the Company purchasing 100,000 shares of its
common stock at the exercise price of $29.505 per share. The closing stock price on the settlement date was $27.98 per share. At June 30, 2003, no put options were outstanding.
Item 4. Controls and Procedures
Within 90 days prior to the filing date of this Quarterly Report on Form 10-Q, the Company carried out an evaluation, under the supervision and with the participation of the Company's management, including the Chief Executive Officer and Chief Financial Officer,
of the effectiveness of the Company's disclosure controls and procedures as defined in Exchange Act Rule 13a-14. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company's current disclosure controls and
procedures are reasonably effective. There have been no significant changes in the Company's internal controls or in other factors that could significantly affect internal controls subsequent to the date of the evaluation by the Chief Executive Officer and Chief
Financial Officer.
25
Part II - Other Information
Item 1. Legal Proceedings
The Company is the subject of numerous lawsuits and claims incidental to the conduct of its or its predecessors' businesses, including lawsuits and claims relating to product liability, personal injury, environmental, contractual, employment and intellectual
property matters. Many of the matters relate to the use, handling, processing, storage, transport or disposal of hazardous materials. The Company believes that the resolution of such lawsuits and claims, including those described below, will not have a
material adverse effect on the consolidated financial position of the Company, but could be material to the consolidated results of operations of the Company in any one accounting period.
Cytec and/or American Cyanamid Company ("Cyanamid"), the Company's former parent company, are among several defendants in approximately 35 cases, pending in various state and federal courts, in which plaintiffs assert claims for personal injury, property damage, and
other claims for relief relating to lead pigment that was used as an ingredient decades ago in paint for use in buildings. Cytec has an agreement to indemnify Cyanamid in connection with such suits. The different suits were brought by government
entities and/or individual plaintiffs, on behalf of themselves and others. The suits variously seek injunctive relief and compensatory and punitive damages, including funds for the cost of monitoring, detecting and removing lead based paint from buildings and
for medical monitoring; for personal injuries allegedly caused by ingestion of lead based paint; and plaintiffs' attorneys' fees. The Company and Cyanamid believe that the suits against them are without merit and are vigorously defending against all such
claims.
The Company has access to a substantial amount of primary and excess general liability insurance for property damage under policies issued to Cyanamid. The Company believes these policies are available to cover a significant portion of both its defense costs
and indemnity costs, if any, for lead pigment-related property damage claims. The Company is currently pursuing an agreement with various of its insurers concerning coverage with respect to these matters.
In January 1999 the Company received a subpoena to testify before, and provide documents to, a federal grand jury in California investigating the carbon fiber and prepreg industry. The Company manufactures prepregs as part of its advanced composites product
line and, since its acquisition of BP’s carbon fibers business in August 2001, also manufactures carbon fiber. The Company has no reason to believe that it is a target of the grand jury investigation. After the grand jury investigation was
commenced, the Company and the other companies subpoenaed to testify before the grand jury were named as defendants in civil antitrust class actions in state and federal courts in California on behalf of purchasers of carbon fiber, which the complaints defined to
include prepregs manufactured from carbon fiber. In each case the complaint alleges that the defendants, manufacturers of carbon fiber and/or prepregs manufactured therefrom, conspired to fix the prices of their products. The Company and other companies
have also been named as defendants in a state civil antitrust action in the state court of Massachusetts and an action brought on in the U.S. district court of California on behalf of a plaintiff that opted out of the plaintiff class in the California federal court
class action.
26
The Company denies that it conspired to fix prices. In connection with its acquisition of BP's carbon fibers business, the Company was indemnified by BP on various matters including any liabilities BP's carbon fibers
business may have in these proceedings. The indemnity does not cover any liability the Company may have in its own right and not as a successor to BP's carbon fibers business.
See also the first four paragraphs of "Environmental Matters" under “Business” in Item 1 of the Company's 2002 Annual Report on Form 10-K and Note 8 of the Notes to the Consolidated Financial Statements (unaudited) on Part I, Item (1).
In addition to liabilities with respect to the specific cases described above, because the production of certain chemicals involves the use, handling, processing, storage, transportation and disposal of hazardous materials, and because certain of the Company's
products constitute or contain hazardous materials, the Company has been subject to claims of injury from direct exposure to such materials and from indirect exposure when such materials are incorporated into other companies' products. There can be no
assurance that, as a result of past or future operations, there will not be additional claims of injury by employees or members of the public due to exposure, or alleged exposure, to such materials.
Furthermore, the Company also has exposure to present and future claims with respect to workplace exposure, workers' compensation and other matters, arising from past events.
Item 4. Submission of Matters to a Vote of Security Holders
The Company held its annual meeting of Common Stockholders on April 17, 2003. At this meeting, the following matters were voted on:
1. Election of Directors – J.E. Akitt, F.W. Armstrong, and J.R. Stanley were elected Directors at the Annual Meeting for terms ending in the years indicated below by the following margins:
Name – Year Term Expires |
|
Votes For |
|
Votes Withheld |
|
|
|
|
|
J.E. Akitt (2006) |
|
32,434,634 |
|
1,793,214 |
F.W. Armstrong (2004) |
|
32,442,222 |
|
1,785,626 |
J.R. Stanley (2006) |
|
33,475,077 |
|
752,771 |
2. Ratification of KPMG LLP as the Company’s independent accountants for 2003.
For |
|
Against |
|
Abstain |
|
|
|
|
|
32,473,219 |
|
1,684,914 |
|
69,715 |
3. The Amended and Restated 1993 Stock Award and Incentive Plan was approved at the Annual Meeting by the following margin:
For |
|
Against |
|
Abstain |
|
|
|
|
|
18,703,985 |
|
15,298,978 |
|
224,885 |
27
Item 6. Exhibits and Reports on Form 8-K
(a). Exhibits
See Exhibit Index on page 30 for exhibits filed with this Quarterly Report on Form 10-Q.
(b). Reports on Form 8-K
The Company filed a current report on Form 8-K dated April 17, 2003 regarding its disclosure of results of operations and financial condition for the first quarter of 2003.
28
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CYTEC
INDUSTRIES INC.
By: /s/ James P. Cronin
James
P. Cronin
Executive
Vice President and
Chief
Financial Officer
July 30, 2003
29
4.1 |
|
Underwriting Agreement dated June 24, 2003 among the Registrant and Wachovia Securities, LLC, ABN AMRO Incorporated and each of the other underwriters named in the Underwriting Agreement. |
4.2 |
|
4.60% Senior Note due 2013. |
10.12 |
|
Cytec Executive Supplemental Savings and Profit Sharing Plan (incorporated by reference herein from the Registrant’s Registration Statement on Form S-8 dated July 22, 2003, Reg. No. 333- ). |
12 |
|
Computation of Ratio of Earnings to Fixed Charges for the three and six months ended June 30, 2003 and 2002. |
31.1 |
|
Certification of David Lilley, Chief Executive Officer Pursuant To Rule 13a-14(a), As Adopted Pursuant To Section 302 Of The Sarbanes-Oxley Act of 2002. |
31.2 |
|
Certification of James P. Cronin, Chief Financial Officer Pursuant To Rule 13a-14(a), As Adopted Pursuant To Section 302 Of The Sarbanes-Oxley Act of 2002. |
32.1 |
|
Certification of David Lilley, Chief Executive Officer Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 Of The Sarbanes-Oxley Act Of 2002 |
32.2 |
|
Certification of James P. Cronin, Chief Financial Officer Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 Of The Sarbanes-Oxley Act Of 2002 |
30